Alcohol interaction with metformin
Pro Research Analysisby 
Searched over 200M research papers
Metformin and Alcohol Interaction: Safety and Risk Considerations
Metformin is widely used to manage type 2 diabetes and is generally considered safe, but caution is advised when it is taken with alcohol. This is because both metformin and alcohol can independently increase the risk of lactic acidosis, a rare but serious condition. Therefore, patients are advised to be careful with alcohol consumption while on metformin, regardless of whether they have liver problems or not .
Metformin’s Effects on Alcohol-Induced Liver Injury
Research in animal models shows that metformin can actually protect the liver from alcohol-induced damage. In mice, metformin significantly reduced the buildup of fat in the liver and lessened liver inflammation caused by both acute and chronic alcohol exposure. This protective effect is linked to the drug’s ability to prevent the increase of a protein called plasminogen activator inhibitor-1 (PAI-1), which is associated with liver injury from alcohol .
Metformin and Alcohol Consumption Behavior
Studies in mice suggest that metformin may help reduce harmful, binge-like alcohol drinking. In experiments, metformin lowered alcohol intake in both male and female mice without affecting how quickly alcohol was cleared from their bodies. This points to the potential for metformin to be used as a treatment to help reduce excessive alcohol consumption .
Neuroprotective Effects of Metformin Against Alcohol Damage
Metformin also appears to protect the brain from alcohol-induced damage. In animal models of fetal alcohol spectrum disorders, metformin reduced inflammation, oxidative stress, and cell death in the brain. This suggests that metformin may help counteract some of the harmful effects of alcohol on the nervous system .
Metformin, Gut Microbiota, and Ethanol Production
Another area of research looks at how metformin affects gut bacteria that produce ethanol, especially in the context of non-alcoholic fatty liver disease (NAFLD). While metformin reduced the number of ethanol-producing bacteria in the gut, it did not significantly lower the total amount of ethanol produced. This means that the benefits of metformin in NAFLD are likely not due to changes in gut ethanol production .
Conclusion
In summary, while caution is needed when combining metformin and alcohol due to the risk of lactic acidosis, research shows that metformin may protect against alcohol-induced liver and brain damage and could even help reduce harmful drinking behaviors. However, its benefits in liver disease are not related to changes in gut ethanol production. Patients should always consult their healthcare provider about alcohol use while taking metformin 1234+1 MORE.
Sources and full results
Most relevant research papers on this topic
Metformin prevents alcohol-induced liver injury in the mouse: Critical role of plasminogen activator inhibitor-1.
Metformin prevents alcohol-induced liver injury in mice by preventing the upregulation of plasminogen activator inhibitor-1, a key player in hepatic injury caused by ethanol.
Effects of metformin on binge-like ethanol drinking and adenosine monophosphate kinase signaling in inbred High Drinking in the Dark - Line 1 mice
Metformin, an affordable and safe diabetes medication, can reduce binge-like ethanol intake in mice, potentially benefiting individuals with alcohol use disorder.
Anti-inflammatory, Antioxidant, and Antiapoptotic Action of Metformin Attenuates Ethanol Neurotoxicity in the Animal Model of Fetal Alcohol Spectrum Disorders
Metformin reduces ethanol-related neuroinflammation and apoptosis in the hippocampus of adult rats, offering potential neuroprotective effects.
Detection and Quantification of Some Ethanol-Producing Bacterial Strains in the Gut of Mouse Model of Non-Alcoholic Fatty Liver Disease: Role of Metformin
Metformin does not significantly impact ethanol-producing gut bacteria, but may improve liver function and reduce inflammation in a mouse model of non-alcoholic fatty liver disease.
Hepatic exposure of metformin in patients with non‐alcoholic fatty liver disease
Metformin biodistribution to the liver in patients with non-alcoholic fatty liver disease is not significantly affected, suggesting its potential role in treating type 2 diabetes and reducing cardiovascular events.
Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Non-alcoholic Steatohepatitis-related, Child-Pugh A Cirrhosis.
Metformin use in patients with nonalcoholic steatohepatitis and Child-Pugh A cirrhosis is associated with higher survival rates and lower rates of liver-related complications.
DOI